Landscapes / Targets
survivin
5 drugs act on survivin, in 6 active trials · Any stage · updated 18 Nov 2026
FollowEvery change as it happens, and a Monday email
Drugs5
| Drug | How it works | Company | Stage
Sources: FDA: the drug development process, ClinicalTrials.gov glossary | Next date
| Details |
|---|---|---|---|---|---|
— |
Phase 2 | 30 Sep 2028Phase 2 trial completes | |||
| Next date | 30 Sep 2028 · Phase 2 trial completes | ||||
| Also tested for | Glioblastoma | ||||
| Open drug page | |||||
— |
Phase 2 | — | |||
| Also tested for | Relapsed Diffuse Large B-cell Lymphoma, Refractory Diffuse Large B-cell Lymphoma | ||||
| Open drug page | |||||
— |
Phase 1/2 | — | |||
| Also tested for | Non Small Cell Lung Cancer | ||||
| Open drug page | |||||
— |
Phase 1 | — | |||
| Also tested for | Oropharyngeal Cancer, Human Papilloma Virus and 9 more | ||||
| Open drug page | |||||
— |
Phase 1 | — | |||
| Also tested for | Prostate Cancer, Non Small Cell Lung Cancer and 1 more | ||||
| Open drug page | |||||
No drugs match “”.
About this list
- Checked
- 5 of 5 drugs. How we check
- Matches
- The mechanism of checked drugs, and drug names, so a drug not checked yet may be missing.
- Sources
- ClinicalTrials.gov updated 18 Nov 2026 · openFDA updated 17 Nov 2026